Recommended Dosages for Clopidogrel and Enoxaparin
For clopidogrel: use a 300-600 mg loading dose followed by 75 mg daily maintenance; for enoxaparin: dosing varies by clinical scenario but typically 1 mg/kg subcutaneous every 12 hours for initial therapy or specific weight-based IV boluses for PCI support.
Clopidogrel Dosing
Loading Dose
The loading dose depends on clinical context and timing:
- Primary PCI for STEMI: 600 mg loading dose 1, 2
- After fibrinolytic therapy:
- Acute coronary syndrome (general): 300 mg loading dose per FDA labeling 6, though higher doses (600 mg) achieve faster and more complete platelet inhibition 7
Maintenance Dose
- 75 mg once daily for all indications 1, 2, 3, 6
- Continue for at least 12 months after stent placement (drug-eluting or bare-metal) 3, 4, 5
Important caveat: The 300 mg loading dose is FDA-approved and evidence-based, but initiating without a loading dose delays antiplatelet effect by several days 6. The 600 mg dose provides superior platelet inhibition and may reduce clinical events 7, though this higher loading is not universally mandated in all guidelines.
Enoxaparin Dosing
Initial Therapy (Non-PCI Setting)
- 1 mg/kg subcutaneous every 12 hours 2, 8
- Renal adjustment: If creatinine clearance <30 mL/min, reduce to 1 mg/kg subcutaneous once daily 2, 8
With Fibrinolytic Therapy
- Age <75 years: 30 mg IV bolus, followed 15 minutes later by 1 mg/kg subcutaneous every 12 hours (maximum 100 mg for first 2 doses) 1, 2, 8
- Age ≥75 years: No IV bolus; start with 0.75 mg/kg subcutaneous every 12 hours (maximum 75 mg for first 2 doses) 1, 2, 8
- Renal impairment (any age): If CrCl <30 mL/min, give 1 mg/kg subcutaneous every 24 hours 1, 2, 8
To Support PCI
- If last subcutaneous dose within 8 hours: No additional enoxaparin needed 2, 3, 4, 2, 8
- If last dose 8-12 hours earlier OR only 1 dose given: 0.3 mg/kg IV bolus 2, 3, 4, 2, 8
- No prior anticoagulant therapy: 0.5-0.75 mg/kg IV bolus 2, 8
Primary PCI (Without Prior Anticoagulation)
- 0.5 mg/kg IV bolus 1
Key Clinical Considerations
Timing matters critically: The most recent 2025 ACC/AHA guidelines 2, 8 provide the most comprehensive dosing tables and should guide contemporary practice. These align closely with the 2012 ESC guidelines 1 but offer more granular detail for complex scenarios.
Common pitfall with enoxaparin: Failing to adjust for the timing of the last subcutaneous dose before PCI can lead to either under-anticoagulation (if >12 hours) or over-anticoagulation with bleeding risk (if additional dose given when last dose was <8 hours ago). Always check the exact timing 2, 8.
Clopidogrel loading dose controversy: While 300 mg is FDA-approved 6, the 600 mg loading provides faster onset and greater platelet inhibition 7. For primary PCI in STEMI, the 600 mg dose is preferred in current guidelines 1, 2. The 300 mg dose remains appropriate when PCI occurs ≤24 hours after fibrinolysis 3, 4, 5.
Weight-based precision for enoxaparin: Use actual body weight for dosing calculations. In morbidly obese patients, doses may need adjustment based on anti-Xa monitoring, as standard 1 mg/kg dosing can lead to supratherapeutic levels 9.